About Irbesartan
IrbesartanEuropean Pharmacopoeia (EP) Reference StandardSynonym: 2-Butyl-3-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-oneCAS Number138402-11-6Empirical Formula (Hill Notation)C25H28N6OMolecular Weight428.53PropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,EP Standards,EP Standards I - K,Pharmacopeia & Metrological Institutes Standardsgrade pharmaceutical primary standardform neatformat neatUnited States Pharmacopeia (USP) Reference StandardPropertiesRelated CategoriesAnalytical Standards,Analytical/Chromatography,Pharmacopeia & Metrological Institutes Standards,USP Standards,USP Standards I - Kgrade pharmaceutical primary standardform neatformat neatPharmaceutical Secondary StandardPropertiesRelated CategoriesAdditional Standards,Analytical Standards,Analytical/Chromatography,Chromatography,Pharmaceutical Secondary Standards,Pharmaceutical and Drug Standards,Pharmacopeia & Metrological Institutes Standards,Secondary Pharmaceutical Standardspharmaceutical secondary standardpackaging pkg of 1g
FAQs of Irbesartan:
Q: What is the appearance of Irbesartan?
A: Irbesartan appears as a white solid.
Q: What is the melting point of Irbesartan?
A: The melting point of Irbesartan is between 180-184C.
Q: What is the molecular formula of Irbesartan?
A: The molecular formula of Irbesartan is C25H28N6O.
Q: What is the molecular weight of Irbesartan?
A: The molecular weight of Irbesartan is 428.53 grams (g).
Q: What are the primary uses of Irbesartan?
A: Irbesartan is indicated for the treatment of hypertension and diabetic nephropathy with elevated serum creatinine and proteinuria (>300 mg/day) in patients with type 2 diabetes and hypertension. It may be used alone or in combination with other antihypertensive agents.